Common Contracts
2 similar License Agreement contracts by Finch Therapeutics Group, Inc.
by and between MICROBIOME HEALTH RESEARCH INSTITUTE, INC. and FINCH THERAPEUTICS, INC. November 19, 2020License Agreement • February 26th, 2021 • Finch Therapeutics Group, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This LMIC License Agreement (the “Agreement”) is entered into as November 19, 2020 (the “Effective Date”), by and between Microbiome Health Research Institute, Inc. d/b/a OpenBiome, a Massachusetts nonprofit corporation, having an address of 2067 Massachusetts Ave, Cambridge, MA 02140 (“OpenBiome”), and Finch Therapeutics, Inc., a corporation organized under the laws of Delaware, having an address of 200 Inner Belt Road, Somerville, MA 02143 (“Finch”). OpenBiome and Finch may each be referred to herein individually as a “Party” and collectively as the “Parties.”
by and between MICROBIOME HEALTH RESEARCH INSTITUTE, INC. and FINCH THERAPEUTICS, INC. November 19, 2020License Agreement • February 9th, 2021 • Finch Therapeutics Group, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This LMIC License Agreement (the “Agreement”) is entered into as November 19, 2020 (the “Effective Date”), by and between Microbiome Health Research Institute, Inc. d/b/a OpenBiome, a Massachusetts nonprofit corporation, having an address of 2067 Massachusetts Ave, Cambridge, MA 02140 (“OpenBiome”), and Finch Therapeutics, Inc., a corporation organized under the laws of Delaware, having an address of 200 Inner Belt Road, Somerville, MA 02143 (“Finch”). OpenBiome and Finch may each be referred to herein individually as a “Party” and collectively as the “Parties.”
